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Aim: To characterize and compare total lung capacity (TLC) measured by plethysmography 
with high-resolution computed tomography (HRCT), and to identify variables that predict the 
difference between the two modalities.
Methods: Fifty-nine consecutive patients referred for the evaluation of COPD were retrospec-
tively reviewed. Patients underwent full pulmonary function testing and HRCT within 3 months. 
TLC was obtained by plethysmography as per American Thoracic Society/European Respiratory 
Society standards and by HRCT using custom software on 0.75 and 5 mm thick contiguous 
slices performed at full inspiration (TLC).
Results: TLC measured by plethysmography correlated with TLC measured by inspiratory 
HRCT (r = 0.92, P , 0.01). TLC measured by plethysmography was larger than that determined 
by inspiratory HRCT in most patients (mean of 6.46 ± 1.28 L and 5.34 ± 1.20 L respectively, 
P , 0.05). TLC measured by both plethysmography and HRCT correlated significantly with 
indices of airflow obstruction (forced expiratory volume in 1 second/forced vital capacity 
[FVC] and FVC%), static lung volumes (residual volume, percent predicted [RV%], total lung 
capacity, percent predicted [TLC%], functional residual capacity, percent predicted [FRC%], 
and inspiratory capacity, percent predicted), and percent emphysema. TLC by plethysmogra-
phy and HRCT both demonstrated significant inverse correlations with diffusion impairment. 
The absolute difference between TLC measured by plethysmography and HRCT increased as 
RV%, TLC%, and FRC% increased. Gas trapping (RV% and FRC%) independently predicted 
the difference in TLC between plethysmography and HRCT.
Conclusion: In COPD, TLC by plethysmography can be up to 2 L greater than inspiratory 
HRCT. Gas trapping independently predicts patients for whom TLC by plethysmography dif-
fers significantly from HRCT.
Keywords: lung capacity, plethysmography, high-resolution computed tomography, gas trap-
ping, lung volume measurement errors
Background
Estimation of lung volume is used to help categorize the type, severity, and progres-
sion of lung diseases, and their response to therapy.1 The overestimation of total lung 
capacity (TLC) by body plethysmograpy compared with high-resolution computed 
tomography (HRCT) (or, as some see it, the underestimation by HRCT compared with 
  plethysmography) is well described in the literature.2–4 The degree to which TLC mea-
sured by body plethysmography differs from HRCT in COPD is not understood. This 
may have significant implications for determining patient eligibility for therapies such 
as lung volume reduction surgery, characterizing a prospective lung transplant recipi-
ent’s lung volume dimensions, or assessing the response to treatment.5 Our objective was 
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to describe the degree to which TLC determination by body 
plethysmography differs from HRCT. Further, we sought to 
identify variables that may predict this difference.
Materials and methods
Study patients
A retrospective review was performed on 71 sequential 
patients referred to our outpatient clinic for the evaluation 
of COPD between September 2008 and December 2008. 
Patients who met the following criteria were extracted: 
(1) obstructive physiology evidenced by forced expiratory 
  volume in 1 second (FEV1)/forced vital capacity (FVC) # 70 
and TLC # 80, (2) no or minimal radiographic abnormalities, 
or (3) complete pulmonary function tests (PFTs) and HRCT 
within 3 months.
PFTs
All patients underwent PFTs that were performed on a body 
plethysmograph (VMax Spectra 22D/62J; Carefusion, Yorba 
Linda, CA) according to the guidelines of the American 
Thoracic   Society/European Respiratory Society. TLC 
was obtained as per American Thoracic Society/European 
Respiratory Society standards.6,7 Patients were excluded if 
they failed to meet criteria for reproducibility, which was 
defined as the patient demonstrating at least three functional 
residual capacity (FRC)pleth values that agree within 5% (two 
patients), or if they failed to perform three to five   technically 
satisfactory panting maneuvers at frequencies at or around 
1 Hertz (two patients).
Chest hRCT
HRCT scans with 0.75 and 5 mm contiguous slices were 
performed at full inspiration using a 16 or 64 MDCT 
scanner (Somatom Sensation; Siemens Medical Systems, 
Erlangen, Germany). Technical parameters included kVp 
of 100–120 determined by estimation of body mass index. 
Patients underwent helical computed tomography (CT) of 
the entire lung at maximum inspiration in the supine posi-
tion. Patients received breathing instructions by recorded 
voice commands from the CT scanner. Custom software 
(Pulmonary W  orkstation Plus, VIDA Diagnostics, Inc, 
Coralville, IA) was used to determine total lung volume, 
tissue volume, and air volume in milliliters, and mean 
lung density in Hounsfield units (HU) for each patient. All 
voxels marked as lung parenchyma were analyzed. Percent 
emphysema was determined as the percentage of voxels 
below thresholds of -950 and -910 HU. Total volume at 
full inspiration represents the TLC by HRCT for all analysis 
(Figure 1). HRCT scans were excluded from analysis for 
radiographic abnormalities other than emphysema including 
parenchymal consolidation, pleural effusion, and previous 
lung volume reduction surgery (LVRS) or transplant surgery 
(two patients). Patients were also excluded from analysis 
when the VIDA software was unable to process the scan 
Figure 1 Diagram of the lungs of a 61-year-old man with COPD. The transverse view (top left), coronal view (top right), and sagittal view (bottom left) are at the same 
anatomical level, as well as three-dimensional rendering of tracheobronchial tree (bottom right).
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Table 1 Demographics in 59 patients with COPD
Variables Mean SD or % total
Age (years) 63 9
Male 27 46%
Caucasian 47 80%
BMI 27 6
Pack-years 41 18
Abbreviations: BMI, body mass index; pack-years, packs of tobacco smoked per 
day × years as a smoker; SD, standard deviation.
Table 2 Pulmonary function in 59 patients with COPD
Variables Mean SD
FEV1/FVC 0.36 0.12
FVC (L) 2.98 0.94
FVC% 85 17
FEV1 (L) 1.08 0.52
FEV1% 41 18
FEF 25–75(L) 0.61 0.23
FEF 25%–75% 29 20
RV (L) 3.38 1.0
RV% 164 48
TLC (L) 6.46 1.28
TLC% 115 15
RV/TLC 0.52 0.11
FRC (L) 4.44 1.08
FRC% 146 32
IC (L) 2.02 0.73
IC% 86 22
IC/TLC 0.31 0.09
DLCO/VA 2.49 0.78
DLCO/VA% 50 15
Abbreviations:  DLCO/VA,  carbon  monoxide  diffusing  capacity  corrected  for 
alveolar  volume;  DLCO/VA%,  carbon  monoxide  diffusing  capacity  corrected 
for alveolar volume, percent predicted; FEF 25–75(L), forced expiratory volume 
during  midexpiratory  flow;  FEF  25%–75%,  forced  expiratory  volume  during 
midexpiratory flow, percent predicted; FEV1, forced expiratory volume in 1 second; 
FEV1%, forced expiratory volume in 1 second, percent predicted; FRC, functional 
residual capacity; FVC, forced vital capacity; FVC%, forced vital capacity, percent 
predicted;  IC,  inspiratory  capacity;  RV,  residual  volume;  RV%,  residual  volume, 
percent predicted; SD, standard deviation; TLC, total lung capacity; TLC%, total 
lung capacity, percent predicted.
Table 3 hRCT in 59 patients with COPD
Variables Mean SD
hRCT total volume (L) 6.05 1.26
hRCT tissue volume (L) 0.71 0.16
hRCT air volume (L) 5.34 1.20
hRCT density (hU) -873.15 29.47
Emphysema less than -950 (%) 27.74 14.9
Emphysema less than -910 (%) 50.54 16.23
Abbreviations: Emphysema less than -950, percent of voxels with hounsfield 
units less than -950; emphysema less than -910, percent of voxels with hounsfield 
units less than -910; hRCT, high-resolution computed tomography; hU, hounsfield 
units; SD, standard deviation.
due to technical difficulties, including failure to identify the 
tracheobronchial tree (six patients).
Statistical analysis
Student’s t-test was used for comparison of TLC by plethys-
mography and HRCT. The Wilcoxon signed rank test was 
used where normality was not met. Spearman’s rank order 
correlation and Bland–Altman analysis were used for com-
parison of TLC by plethysmography and HRCT. Multiple 
linear regressions were used to determine which variables 
accounted for the ability to predict the difference between TLC 
measured by plethysmography and HRCT. Data are presented 
as mean ± standard deviation unless otherwise indicated.
Results
Demographics, pulmonary function data, and HRCT results 
obtained from the 59 patients are reported in Tables 1–3 
respectively. Pulmonary function testing and HRCT were 
performed within 3 ± 20 days of each other. The subject 
population included 18 patients (31%) with Global Initiative 
for Chronic Obstructive Lung Disease (GOLD) II disease, 
22 patients (37%) with GOLD III disease, and 19 patients 
(32%) with GOLD IV disease.8
Total lung volume as measured by plethysmography cor-
related significantly with that measured by HRCT (r = 0.92, 
P , 0.01) (Figure 2). TLC measured by plethysmography 
(average 6.46 ± 1.28 L) was larger than that determined by 
inspiratory HRCT (5.34 ± 1.20 L) in most patients (P , 0.05). 
In Bland–Altman analysis, the average of the two measure-
ments is thought to represent the “true value.” As the true 
value increases the difference between the two modalities also 
increases (Figure 3). The mean TLC measured by plethysmog-
raphy was 1.12 L greater than TLC measured by HRCT.
We found FEV1 to be significantly correlated with percent 
emphysema and mean lung density, a result which agrees 
with that reported by Baldi et al.9 FEV1 was not significantly 
correlated with lung volume measured by plethysmog-
raphy or HRCT, however, or with the difference between 
  plethymography and HRCT (Table 4).
As has been reported by others,10–13 there was fair 
correlation between TLC measured by both plethysmography 
and HRCT with indices of airflow obstruction (FEV1/FVC 
and FVC%), static lung volumes (residual volume, percent 
predicted [RV%], total lung capacity, percent predicted 
[TLC%], functional residual capacity, percent predicted 
[FRC%], inspiratory capacity, percent predicted), and per-
cent emphysema. Both TLC by plethysmography and HRCT 
showed weak but significant inverse correlations with diffu-
sion impairment (Table 5).
The difference between TLC as measured by plethys-
mograhpy and HRCT correlated significantly with static 
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lung volumes (RV%, TLC%, and FRC%) (Table 5, 
Figures 4 and 5). In patients with more severe air trapping 
and hyperinflation, the difference between TLC measured by 
plethysmography and that determined by HRCT increased. 
Using multiple linear regressions, RV% and FRC% indepen-
dently predicted the differences between TLC measured by 
plethysmography and HRCT (Table 6).
Discussion
Thoracic gas volume (TGV) can be measured in several dif-
ferent ways. In patients with COPD, body plethysmography 
is usually preferred to nitrogen washout and gas dilution 
techniques because it is argued that the latter methods are 
unable to measure poorly ventilated or unventilated areas of 
the lung.14–16 While body plethysmography readily measures 
trapped air not in communication with the airways, it is not 
without its own inherent errors, particularly in patients with 
increased airway resistance. TGV is calculated using Boyle’s 
law which states that pressure and volume are inversely 
proportional when temperature is constant. Within the body 
box, pressure at the mouth may not reflect true pressure 
in the alveoli if airway resistance increases.17,18 If alveolar 
pressure is underestimated, thoracic gas volume will be 
overestimated. Rodenstein et al demonstrated this error in 
the measurement of lung volumes by plethysmography when 
airflow obstruction occurs, and found thoracic gas volume 
measured from pressure swings at the mouth (TGVm) to be 1 
or more liters greater than thoracic gas volume measured 
from pressure swings in the esophagus (TGVes), an indirect 
measurement of pleural pressure.19 The authors went on to 
qualify this overestimation of TGV in the setting of airflow 
obstruction as being dependent on panting frequency.20 
TGVm was 1 L greater than TGVes at panting frequencies 
of 2 Hz in asthmatics, while no difference was seen in those 
without asthma. At higher frequencies, the discrepancy 
further increased in asthmatics, again with no difference 
in those without asthma. At lower panting frequencies, no 
difference was found between the two groups.21 This relation-
ship between panting frequency and the overestimation of 
lung volume by plethysmography has also been described in 
patients with COPD.22,23
HRCT is an important method for routine testing for 
COPD. With dedicated post-processing software, rapid 
and reproducible estimates of tissue and air volume, mean 
lung density, percent emphysema, and airway anatomy 
are now available.24,25 Standardized computer-generated 
HRCT instructions have improved reproducibility and 
accuracy.26,27
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Figure 3 This plot of the difference between the methods against their mean 
illustrates the relationship between the measurement error and the true value. 
Total lung capacity measured by plethysmography is 1.12 L greater than total lung 
capacity measured by hRCT. Greater variation from the mean is seen at higher lung 
volumes, suggesting measurement error is greater at higher lung volumes.
Abbreviations: hRCT, high-resolution computed tomography; pleth, plethysmography.
Table 4 Comparison of FEV1% with plethysmography and hRCT
Variables FEV1%
r P
Plethysmography -0.25 0.06
Plethysmography-hRCT 0.05 0.71
hRCT total (L) -0.22 0.10
hRCT tissue (L) 0.26 0.05
hRCT air (L) -0.29 0.03
hRCT density (hU) 0.48 0.00
Emphysema less than -950 (%) -0.43 0.00
Emphysema less than -910 (%) -0.49 0.00
Abbreviations: FEV1, forced expiratory volume in 1 second; RV, residual volume; 
FRC, functional residual capacity; FVC, forced vital capacity; hRCT, high-resolution 
computed tomography; TLC, total lung capacity. 3.0
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Figure 2 Correlation between inspiratory lung volume by hRCT and TLC derived 
from PFT results.
Notes: r = 0.92, P , 0.01.
Abbreviations: hRCT, high-resolution computed tomography; TLC, total lung capacity.
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Table 5 Correlation coefficients for plethysmography, hRCT, and the difference between plethysmography and hRCT
Variables Plethysmography HRCT Plethysmography-HRCT
r P r P r P
FEV1/FVC -0.39 0.00 -0.35 0.01 0.02 0.88
FVC (L) 0.58 0.00 0.66 0.00 0.03 0.84
FVC% 0.06 0.65 0.02 0.87 0.11 0.40
FEV1 (L) 0.06 0.63 0.14 0.28 0.04 0.77
FEV1% -0.25 0.06 -0.22 0.10 0.05 0.71
FEF 25–75 (L) 0.09 0.57 0.08 0.69 0.07 0.80
FEF 25%–75% -0.30 0.05 -0.27 0.06 0.12 0.39
RV (L) 0.69 0.00 0.54 0.00 0.32 0.02
RV% 0.44 0.00 0.28 0.03 0.29 0.03
TLC (L) – – 0.90 0.00 0.31 0.02
TLC% 0.56 0.00 0.34 0.00 0.39 0.00
RV/TLC 0.07 0.60 -0.06 0.67 0.16 0.21
FRC (L) 0.85 0.00 0.74 0.00 0.29 0.03
FRC% 0.48 0.00 0.33 0.01 0.27 0.04
IC (L) 0.38 0.00 0.43 0.00 0.04 0.78
IC% -0.02 0.87 –0.06 0.67 0.07 0.60
IC/TLC -0.13 0.33 –0.05 0.72 –0.07 0.61
DLCO/VA -0.42 0.00 –0.35 0.01 –0.06 0.63
DLCO/VA% -0.42 0.00 –0.35 0.01 –0.05 0.71
hRCT total (L) 0.90 0.00 – – –0.06 0.64
hRCT tissue (L) 0.39 0.00 0.52 0.00 0.10 0.43
hRCT air (L) 0.92 0.00 0.98 0.00 –0.08 0.56
hRCT density (hU) -0.44 0.00 –0.39 0.00 0.20 0.13
% emphysema less than -950 0.43 0.00 0.41 0.00 –0.18 0.18
% emphysema less than -910 0.49 0.00 0.44 0.00 –0.15 0.26
Abbreviations: DLCO/VA, carbon monoxide diffusing capacity corrected for alveolar volume; DLCO/VA%, carbon monoxide diffusing capacity corrected for alveolar 
volume, percent predicted; emphysema less than -950, percent of voxels with hounsfield units less than -950; emphysema less than -910, percent of voxels with hounsfield 
units less than -910; FEF 25–75(L), forced expiratory volume during midexpiratory flow; FEF 25%–75%, forced expiratory volume during midexpiratory flow, percent 
predicted; FEV1, forced expiratory volume in 1 second; FEV1%, forced expiratory volume in 1 second, percent predicted; FRC, functional residual capacity; FVC, forced vital 
capacity; FVC%, forced vital capacity, percent predicted; hRCT, high-resolution computed tomography; hU, hounsfield units; IC, inspiratory capacity; RV, residual volume; 
RV%, residual volume, percent predicted; TLC, total lung capacity; TLC%, total lung capacity, percent predicted.
Lung volume measurement by HRCT remains fraught 
with predictable and unpredictable errors.28 Supine posi-
tioning during HRCT results in a reduction in the size of 
the various subdivisions of the lung.29–32 In normal subjects, 
vital capacity (VC) falls less than 10% when passing from 
the upright to the supine position,33,34 but a reduction of up to 
25% has been described in patients with diaphragm dysfunc-
tion and respiratory muscle weakness, conditions commonly 
seen in patients with COPD.35 However, postural changes in 
VC in patients with COPD have not been well described. 
Unpredictable errors in the measurement of lung volumes by 
HRCT include difficulty with maximum inspiratory maneu-
vers and breath-holding techniques during scanning.36 Using 
spirometric gating, patients with severe airflow obstruction 
have not been shown to reproducibly achieve maximum 
inspiratory volumes during HRCT.37
In similar patient populations, previous authors have shown 
strong correlations between TLC measured by plethysmogra-
phy and HRCT (Zaporozhan et al, Coxson et al, and Gierada 
et al reported r = 0.90, 0.88, and 0.87, respectively).2–4 Given 
what we know about the limitations of plethysmography and 
HRCT in COPD, we expected to find a relationship between 
severity of airflow obstruction and the differences in the 
measurement of TLC between plethsmography and HRCT. If 
TLC by plethysmography is potentially overestimated in the 
setting of increased airway resistance, we postulated that as 
FEV1 decreased there would be greater differences between 
TLC measured by plethysmography and HRCT. We further 
hypothesized that increased airways resistance and subse-
quent air trapping and hyperinflation38 would be associated 
with the overestimation of lung volumes by plethysmography. 
A recent paper by O’Donnell et al compared lung volumes by 
plethysmography and helium dilution with HRCT in COPD,39 
with plethysmographic TLC found to be significantly greater 
than HRCT values, and plethysmographic overestimation 
of TLC reported to be greatest among subjects with FEV1 
, 30% of predicted. This was not found to be the case in 
the current study as differences between TLC measured by 
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the relationship between airflow obstruction and the overes-
timation of plethysmographic TLC. Our data were collected 
at a single center and our methodology was standardized for 
all patients. No mention was made by O’Donnell et al as to 
the effect of hyperinflation and air trapping on lung volume 
determination. Our data suggest that more significant air 
trapping (RV% and FRC%) and hyperinflation (TLC%) is 
present in the COPD patients with the greatest difference in 
TLC measured by plethsmography and HRCT.
Limitations in our study include lack of spirometric 
gating during image acquisition with HRCT. Sub-maximal 
inspiratory maneuvers would have resulted in an underes-
timation of TLC by HRCT compared to plethysmography. 
Another limitation of our study is that the pulmonary func-
tion tests were not necessarily performed on the same day 
as the HRCT, weakening the correlation between these 
modalities.
Understanding the variability with which TLC by 
plethysmography differs from HRCT has important 
implications in the evaluation of patients with COPD. 
Global and regional measurements of lung volumes can 
be important in identifying patients who are most likely to 
benefit from LVRS.40 Similarly, precise volume determina-
tion is necessary to accurately identify suitable donor and 
recipient lungs for transplantation.5 Finally, the ability to 
precisely measure lung volume may be central to deter-
mining the importance of hyperinflation in COPD, and 
the impact of therapies geared to reducing end-expiratory 
lung volumes.
Conclusion
Total lung capacity measured by plethysmography is larger 
than that determined by HRCT in COPD. The degree to 
which TLC measured by plethysmography differs from 
that determined by HRCT is correlated with air trapping 
and hyperinflation. RV% and FRC% predict the difference 
between TLC determined by plethysmography and HRCT. 
Table 6 Multiple linear regressions
Variables Plethysmography-HRCT
t P
RV% -2.14 0.04
TLC% -0.88 0.39
RV/TLC 0.15 0.88
FRC% 2.33 0.03
Abbreviations:  FRC%,  functional  residual  capacity,  percent  predicted;  hRCT, 
high-resolution computed tomography; RV, residual volume; RV% residual volume, 
percent  predicted;  TLC,  total  lung  capacity;  TLC%,  total  lung  capacity,  percent 
predicted.
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Figure  4  Relationship  between  TLC%  predicted  and  difference  between  lung 
volumes determined by plethysmography (pleth) and hRCT.
Notes: r = 0.39, P , 0.01.
Abbreviations: hRCT, high-resolution computed tomography; TLC%, total lung 
capacity, percent.
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Figure 5 Relationship between RV% predicted and difference between lung volumes 
determined by plethysmography (pleth) and hRCT.
Notes: r = 0.29, P , 0.01.
Abbreviations:  hRCT,  high-resolution  computed  tomography;  RV%,  residual 
volume, percent.
plethysmography and HRCT did not change across GOLD 
stages. This relationship between airflow obstruction and the 
plethysmographic overestimation of TLC may not have been 
seen because the current study’s population included a range 
of FEV1 from normal to very severe, and may not be powered 
sufficiently for subgroup analysis among patients with very 
severe airflow obstruction. O’Donnell et al collected data 
from subjects at three hospitals where HRCT and plethysmo-
graphic technique may not have been standardized. Patients 
recruited from one of the hospitals undergoing evaluation 
for LVRS had substantially lower average FEV1 than those 
from the other two hospitals. Subtle differences in HRCT and 
plethysmographic technique at this hospital may have driven 
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The method used to obtain TLC in severely hyperinflated 
patients needs to be considered when precise measurements 
are required for clinical decision making.
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